Explore

Cancer Summit 2020

Global Summit On Cancer Research & Therapy 2020

London, United Kingdom
22 - 23 July 2020
63 days since the conference ended

Important Dates

Early Bird Deadline
15th June 2020
Abstract Submission Deadline
6th July 2020
Abstract Acceptance Notification
6th July 2020
Final Abstract / Full Paper Deadline
13th July 2020

About Cancer Summit 2020

Gavin Conferences invites participants from all over the world to attend “Global Summit on Cancer Research & Therapy”. Cancer Summit 2020 Conference going to be held at London, UK from July 22-23, 2020 and is open to attendees, academics and non-academic audiences. Theme: Current Advancements in the field of Cancer Treatment

Topics

Cancer, Cancer research, Colorectal cancer, Cancer treatments, Cancer biology, Cancer and cell biology, Organ based cancers, Cancer imaging, Cancer biomarkers, Ocular oncology, Pediatric oncology nursing, Adolescent oncology, Gynaecology oncology, Surgical oncology, Hemato-oncology and blood cancers, Cancer and oncology nursing, Neonatal oncology and hematology, Neonatal hematology-oncology, Surgical oncology nursing, Immuno-oncology, Oncology

Call for Papers

Gavin Conferences invites participants from all over the world to attend “Global Summit on Cancer Research & Therapy”. Cancer Summit 2020 Conference going to be held at London, UK from July 22-23, 2020 and is open to attendees, academics. Cancer, Cancer Research, Cancer Therapy, Cancer Biomarkers, Cancer & Stem Cell Therapy, Chemotherapy, Cancer Immunotherapy, Cancer Vaccines, Radiation Therapy, Surgical Oncology, Breast Cancer & Surgery, Organ Specific Cancer, Gynecological Oncology, Neonatal and Pediatric Oncology, Cancer Cell Biology & Genetics, Cancer Biopsy, Cancer Pharmacology, Cancer Nanotechnology, Cancer Epidemiology, Metastatic Cancer, Cancer Nursing, Complementary & Alternative Therapies for Cancer, Cancer Prevention and Control.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.